NM_032444.4:c.3782C>T
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1
The NM_032444.4(SLX4):c.3782C>T(p.Pro1261Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000688 in 1,613,346 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1261S) has been classified as Uncertain significance.
Frequency
Consequence
NM_032444.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group PInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032444.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLX4 | NM_032444.4 | MANE Select | c.3782C>T | p.Pro1261Leu | missense | Exon 12 of 15 | NP_115820.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLX4 | ENST00000294008.4 | TSL:5 MANE Select | c.3782C>T | p.Pro1261Leu | missense | Exon 12 of 15 | ENSP00000294008.3 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152144Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000350 AC: 87AN: 248770 AF XY: 0.000207 show subpopulations
GnomAD4 exome AF: 0.0000705 AC: 103AN: 1461084Hom.: 1 Cov.: 37 AF XY: 0.0000523 AC XY: 38AN XY: 726884 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74442 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
DNA sequence analysis of the SLX4 gene demonstrated a sequence change, c.3782C>T, in exon 12 that results in an amino acid change, p.Pro1261Leu. This sequence change has been described in gnomAD with a frequency of 0.24% (dbSNP rs374056556) in the Latino sub-population. The p.Pro1261Leu change affects a highly conserved amino acid residue located in a domain of the SLX4 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Pro1261Leu substitution. This sequence change does not appear to have been previously described in patients with SLX4-related disorders. Due to the lack of sufficient evidences, the clinical significance of the p.Pro1261Leu change remains unknown at this time.
Fanconi anemia Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at